2011 - Fellow of the Royal Society of Canada Academy of Science
Eduardo L. Franco focuses on Cervical cancer, Gynecology, Internal medicine, HPV infection and Immunology. He has researched Cervical cancer in several fields, including Human papillomavirus, Mass screening and Vaccination. His research in Gynecology intersects with topics in Cancer, Colposcopy, Randomized controlled trial, Confidence interval and Pap test.
As part of his studies on Internal medicine, Eduardo L. Franco often connects relevant areas like Oncology. In his research, Sexual transmission is intimately related to Virology, which falls under the overarching field of HPV infection. His studies deal with areas such as Young adult, Genital warts, Cohort study and HPV vaccines as well as Immunology.
Eduardo L. Franco mostly deals with Cervical cancer, Gynecology, Internal medicine, HPV infection and Cancer. His biological study spans a wide range of topics, including Human papillomavirus, Epidemiology and Vaccination. His study looks at the relationship between Gynecology and fields such as Cytology, as well as how they intersect with chemical problems.
His Internal medicine study frequently draws connections to adjacent fields such as Oncology. His research on HPV infection also deals with topics like
His scientific interests lie mostly in Internal medicine, Cervical cancer, Human papillomavirus, Vaccination and Confidence interval. As part of his studies on Internal medicine, he often connects relevant subjects like Oncology. His Cervical cancer research is multidisciplinary, incorporating perspectives in Cervix, Viral load and Obstetrics.
His Vaccination research includes themes of Cervical cancer incidence, Logistic regression, Public health, Hpv vaccination and HPV infection. His Confidence interval study also includes
Eduardo L. Franco mainly investigates Confidence interval, Internal medicine, Odds ratio, Vaccination and Young adult. His Confidence interval research incorporates elements of Vaginal Douching, Bathing, Physiology and Hygiene. His Internal medicine research focuses on Cervical cancer and Cancer.
His research integrates issues of Cytology, Oncology and MEDLINE in his study of Cervical cancer. His Odds ratio study combines topics in areas such as Logistic regression, Surgery, Cohort and Receiver operating characteristic. His Young adult study combines topics from a wide range of disciplines, such as Prospective cohort study, Cohort study and Obstetrics.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial
Diane M. Harper;Eduardo L. Franco;Cosette Wheeler;Daron Gale Ferris.
The Lancet (2004)
Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial
Diane M Harper;Eduardo L Franco;Cosette M Wheeler;Anna-Barbara Moscicki.
The Lancet (2006)
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer
Debbie Saslow;Diane Solomon;Herschel W. Lawson;Maureen Killackey.
CA: A Cancer Journal for Clinicians (2012)
Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.
Marie-Hélène Mayrand;Eliane Duarte-Franco;Isabel Rodrigues;Stephen D. Walter.
The New England Journal of Medicine (2007)
The epidemiology of genital human papillomavirus infection.
Helen Trottier;Eduardo L. Franco.
Vaccine (2006)
Epidemiology of Acquisition and Clearance of Cervical Human Papillomavirus Infection in Women from a High-Risk Area for Cervical Cancer
Eduardo L. Franco;Luisa L. Villa;Joao P. Sobrinho;José M. Prado.
The Journal of Infectious Diseases (1999)
Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection
Eduardo L. Franco;Eliane Duarte-Franco;Alex Ferenczy.
Canadian Medical Association Journal (2001)
Epidemiology and transmission dynamics of genital HPV infection
Ann N. Burchell;Rachel L. Winer;Silvia De Sanjose;Eduardo L. Franco.
Vaccine. Supplement (2006)
Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia.
Nicolas F. Schlecht;Sophie Kulaga;Juliette Robitaille;Silvaneide Ferreira.
JAMA (2001)
Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine
Sue J. Goldie;Michele Kohli;Daniel Grima;Milton C. Weinstein.
Journal of the National Cancer Institute (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Montreal
Universidade de São Paulo
University of British Columbia
Cincinnati Children's Hospital Medical Center
Albert Einstein College of Medicine
Queen Mary University of London
Simon Fraser University
University of California, Los Angeles
Open University of Catalonia
McMaster University
University of Adelaide
Columbia University
Rambus (United Kingdom)
Wuhan University
Utrecht University
Zhejiang University
Bard College
Max Planck Society
University of Tokyo
Vrije Universiteit Amsterdam
Medical University of Vienna
University of Colorado Anschutz Medical Campus
University of Connecticut
University of Stirling
Oregon Health & Science University
University of Helsinki